Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Raymond A. Lorenz"'
Publikováno v:
Population health management. 25(6)
Rising prescription costs, poor medication adherence, and safety issues pose persistent challenges to employer-sponsored health care plans and their beneficiaries. Comprehensive medication management (CMM), a patient-centered approach to medication o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97087c0ef0a0466e2507826dd17e948c
https://pubmed.ncbi.nlm.nih.gov/36301527
https://pubmed.ncbi.nlm.nih.gov/36301527
Autor:
Murray Keogh, Maren S. Fragala, Arul Prakasam Peter, Raymond A. Lorenz, Steven E. Goldberg, Jeffrey A. Shaman
Publikováno v:
Journal of occupational and environmental medicine. 64(12)
The aims of the study are to assess adoption of a pharmacogenomic-enriched comprehensive medication management program in a self-insured employer setting and to better understand medication risks that affect employees.Employees were identified to be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::033d7c62a440dbf9467b68be96670c93
https://pubmed.ncbi.nlm.nih.gov/36155954
https://pubmed.ncbi.nlm.nih.gov/36155954
Publikováno v:
Journal of Geriatric Psychiatry and Neurology. 33:324-332
Objective: We compared economic outcomes when elderly patients with neuropsychiatric disorders received psychotropic medications guided by a combinatorial pharmacogenomic (PGx) test. Methods: This is a subanalysis of a 1-year prospective assessment o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eaed58a9a56d39e244184475bf5c969
https://doi.org/10.1177/0891988719892341
https://doi.org/10.1177/0891988719892341
Publikováno v:
Journal of Neuroimmunology. 367:577877
Reports suggested an association between SARS-CoV-2 infection and GBS, but subsequent studies produced conflicting results regarding the incidence of GBS during the pandemic. This study assessed positivity rates for GQ1b, GM-1, GD1a, and GD1b for tes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eef586ee6f3dd80c2691f2cdf919bfb9
https://doi.org/10.1016/j.jneuroim.2022.577877
https://doi.org/10.1016/j.jneuroim.2022.577877
Publikováno v:
Pharmacogenomics and Personalized Medicine
Eve S Fields,1 Raymond A Lorenz,2 Joel G Winner2 1Northwest Center for Community Mental Health, Reston, VA, USA; 2Assurex Health, Mason, OH, USA Abstract: This report describes two cases in which pharmacogenomic testing was utilized to guide medicati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c3f85109b3a9d98bada374b36ba5e5b
http://europepmc.org/articles/PMC4993396
http://europepmc.org/articles/PMC4993396
Publikováno v:
The International Journal of Psychiatry in Medicine. 46:1-13
Objective: To determine influenza (flu) vaccination status among the mentally ill population and identify factors associated with vaccination status. Method: A non-interventional, cross-sectional study was conducted. A self-administered survey to inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94a746884c486bbfbfd266d5e8b62aca
https://doi.org/10.2190/pm.46.1.a
https://doi.org/10.2190/pm.46.1.a
Autor:
Michelle L. Cannon-Breland, David M. Shannon, Bruce A. Berger, Salisa C. Westrick, Jan Kavookjian, Raymond A. Lorenz
Publikováno v:
Journal of the American Pharmacists Association. 53:390-399
To identify the extent of pharmacists' self-reported antidepressant counseling (SRAC) and to identify factors that may affect pharmacists' decisions to provide antidepressant counseling.Cross-sectional study.Alabama community pharmacies in 2011.Full-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3c106f067a78826f6ca5d22e994153b
https://doi.org/10.1331/japha.2013.12112
https://doi.org/10.1331/japha.2013.12112
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 33:344-359
Major depressive disorder (MDD) is a chronic mental illness that affects an estimated 5–26% of adults at some time in their lives. Treatment is often started as pharmacotherapy using a single drug such as a selective serotonin reuptake inhibitor. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfaadcf9c3bbab6ea3102301659d2122
https://doi.org/10.1002/phar.1204
https://doi.org/10.1002/phar.1204
Publikováno v:
Nutrition in Clinical Practice. 25:143-159
Eating disorders are complex, chronic disorders that are difficult to treat. In addition, the 2 primary eating disorders, anorexia nervosa and bulimia nervosa, may have acute, life-threatening consequences. Medication trials for eating disorders have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd394883a0124422088641fda9a2682d
https://doi.org/10.1177/0884533610362239
https://doi.org/10.1177/0884533610362239
Publikováno v:
The International Journal of Psychiatry in Medicine. 38:81-90
Objective: To report the results from a retrospective chart review looking at the combination of linezolid and serotonergic antidepressants and to report two cases of serotonin syndrome which were identified at our hospital. Case Summary: During the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21e77f694ff0bb5baa648b6be34b70d4
https://doi.org/10.2190/pm.38.1.h
https://doi.org/10.2190/pm.38.1.h